Dabigatran (Pradaxa).

AJNR. American Journal of Neuroradiology
J Comin, D F Kallmes

Abstract

Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring.

References

Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Nov 3, 2010·Annals of Internal Medicine·James V FreemanMintu P Turakhia
Jul 7, 2011·Current Treatment Options in Cardiovascular Medicine·Greg Flaker, Richard Weachter

❮ Previous
Next ❯

Citations

Aug 1, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Xiaoping Xu, Qian Liang
Jun 2, 2021·Journal of Pharmaceutical Health Care and Sciences·Naoto IshikawaNariyasu Mano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.